A Clinical Study on Management of Vandhyatva Due to Anovulatory Cycle with Mahanarayana Taila Nasya and Uttarbasti
R Meera1, MA Pandya2, CH Tanna3, LP Dei4, SB Donga5
1 M.D. (Ayu), Dept. of Stree roga & Prasutitantra, Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India 2 H.O.D. Prasutitantra, Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India 3 Gynaecologist, Jeevan Deep Hospital, Jamnagar, India 4 Reader, Prasutitantra, Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India 5 Lecturer, Prasutitantra, Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
Correspondence Address:
R Meera M.D. (Ayu), Dept. of Stree roga & Prasutitantra, Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar India
 Source of Support: None, Conflict of Interest: None  | Check |

|
The term Vandhyatva (female infertility) is considered as one of the Vatik disorders among 80 types of Vata vyadhi in Ayurvedic texts. Mahanarayana taila mentioned in Yogatarangini in Vatarogaprakarana (38-47) in the form of Nasya and Uttarbasti, for failure to conceive is supposed to be one of the effective therapy in this field. A clinical study on 33 selected patients of female infertility having anovulatory factor, being diagnosed by TVS (Trans vaginal sonography for 2 consecutive cycles) were divided in to 3 groups, Gr-A-(n=11)for Nasya, Gr-B-(n=12) for Uttarbasti & Gr-C(n=10)-(placebo control)). In Nasya group 8 drops of Mahanarayana taila were administred in each nostril for 7days - 3days break and again for 7days, for two consecutive cycles after cessation of bleeding. In Group-B 5ml of Mahanarayana taila was administered in form of Uttarbasti, for consecutive 2cycles, for 3 days after cessation of bleeding. In Group C 500mg capsule filled with roasted wheat flour powder twice a day was administered for consecutive two cycles with water. In this study, 66.66% ovulation occured in Nasya administered group, 28.57 % ovulation occurred in Uttarabasti administered group and 25% ovulation occurred in control group. |